Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | MDS genomics: diagnosis and prognosis

Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the characteristic mutation patterns in myelodysplastic syndromes (MDS) and their importance in the diagnosis and prognosis of the disease. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.